1st longer term tirzepatide study (3 years) episode artwork

EPISODE · Nov 14, 2024 · 44 MIN

1st longer term tirzepatide study (3 years)

from Docs Who Lift · host Docs Who Lift

Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis.Learn:If people lose weight and keep it off with tirzepatideHow many people regain weight after stopping the medicineLong-term side effectsIf semaglutide helps with osteoarthritisClick here to read the tirzepatide studyClick here to read the semaglutide study Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Nov 14, 2024

Embed this episode

Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

1st longer term tirzepatide study (3 years)

0:00 44:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Docs Who Lift?

This episode is 44 minutes long.

When was this Docs Who Lift episode published?

This episode was published on November 14, 2024.

Can I download this Docs Who Lift episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!